0001387131-18-000786.txt : 20180223
0001387131-18-000786.hdr.sgml : 20180223
20180223180440
ACCESSION NUMBER: 0001387131-18-000786
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180221
FILED AS OF DATE: 20180223
DATE AS OF CHANGE: 20180223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CARLO DENNIS J PHD
CENTRAL INDEX KEY: 0001038322
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36242
FILM NUMBER: 18638043
MAIL ADDRESS:
STREET 1: PO BOX 1176
CITY: RANCHO SANTA FE
STATE: CA
ZIP: 92067
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adamis Pharmaceuticals Corp
CENTRAL INDEX KEY: 0000887247
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 820429727
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11455 EL CAMINO REAL
STREET 2: SUITE 310
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 997-2400
MAIL ADDRESS:
STREET 1: 11455 EL CAMINO REAL
STREET 2: SUITE 310
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: CELLEGY PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19950615
4
1
carlo-form4_022118.xml
OWNERSHIP DOCUMENT
X0306
4
2018-02-21
0
0000887247
Adamis Pharmaceuticals Corp
ADMP
0001038322
CARLO DENNIS J PHD
C/O ADAMIS PHARMACEUTICALS CORPORATION
11682 EL CAMINO REAL, SUITE 300
SAN DIEGO
CA
92130
1
1
0
0
President & CEO
Employee Stock Option (right to buy)
2.83
2018-02-21
4
A
0
166934
0
A
2028-02-21
Common Stock
166934
166934
D
Restricted Stock Units
2018-02-21
4
A
0
83467
0
A
Common Stock
83467
83467
D
The option vests and becomes exercisable as to 1/36 of the option shares on each monthly anniversary of the grant date.
Each restricted stock unit (RSU) represents a contingent right to receive one share of the issuer's common stock. 1/3 of the RSUs vest on each anniversary of the grant date over a three year period provided that the Reporting Person has continued to provide services to the Company during such period.
/s/ Robert O. Hopkins, Power of Attorney for Dennis J. Carlo, Ph.D.
2018-02-23